Genmab — Marts 2019
-
Det er vel dem som sælger ud i panik når kursen falder...måske.
-
Måske..
-
Alle vil nok købe til så lav kurs som muligt...osse de store.
-
top 20 er nu 51.29%. Proev og check om 1 maaneds tıd saa er vı nok over 52% https://www.morningstar.com/stocks/lts/0mgb/quote.html
-
Passing of Genmab A/S’ Annual General Meeting http://www.globenewswire.com/news-release/2019/03/29/1788373/0/en/Passing-of-Genmab-A-S-Annual-General-Meeting.html?culture=fr-ca
-
Seattle Genetics Completes Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer http://investor.seattlegenetics.com/news-releases/news-release-details/seattle-genetics-completes-enrollment-phase-2-clinical-trial
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
